Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$3,837,172
-$812,539 QoQ
Shares Held
159,351
-3.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#708
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aviance Capital Partners, LLC holds $78,033,539 across 10 Drug Manufacturers - General names. PFE ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
147,328 | $37,073,617 | |
| 2 | AMGN |
Amgen Inc
|
36,998 | $13,397,715 | |
| 3 | JNJ |
Johnson & Johnson
|
36,810 | $9,348,635 | |
| 4 | MRK |
Merck & Co., Inc.
|
42,110 | $5,411,135 | |
| 5 | PFE |
Pfizer Inc
This page
|
159,351 | $3,837,172 | |
| 6 | LLY |
ELI LILLY & Co
|
3,181 | $3,815,387 | |
| 7 | NVO |
Novo Nordisk A S
|
49,981 | $2,396,089 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
32,102 | $1,849,717 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,837,172 | 159,351 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $4,649,711 | 165,588 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $3,395,588 | 136,369 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $3,557,288 | 139,611 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,389,482 | 98,576 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $2,526,271 | 99,695 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $3,694,992 | 139,276 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,563,013 | 88,563 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,510,309 | 89,718 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,543,398 | 91,654 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $1,914,189 | 66,488 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,280,570 | 68,754 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $2,575,853 | 70,225 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $2,864,486 | 70,208 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,474,533 | 67,809 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,935,639 | 67,085 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,560,731 | 67,914 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $3,515,234 | 67,901 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $4,027,032 | 68,197 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $2,932,722 | 68,187 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,634,841 | 67,284 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,447,481 | 67,554 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $2,471,386 | 67,139 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,458,970 | 67,002 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $2,189,659 | 66,962 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $2,170,491 | 66,498 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||